1. Hematology, University Hospital and University of Zurich, Zurich, Switzerland;
2. Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan;
3. Department of Immunobiology, Yale University, New Haven, CT;
4. Institute of Virology, Technische Universität München, Helmholtz Zentrum München, Munich, Germany;
5. Division of Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany;
6. Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA;
7. Section of Hematology, Department of Internal Medicine and
8. Yale Cancer Center, Yale University School of Medicine, New Haven, CT; and
9. Howard Hughes Medical Institute, Yale University, New Haven, CT